319 related articles for article (PubMed ID: 30857347)
1. In Silico Molecular Docking and In Vivo Validation with
Jeong J; Kim H; Choi J
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857347
[TBL] [Abstract][Full Text] [Related]
2. Identification of an estrogenic hormone receptor in Caenorhabditis elegans.
Mimoto A; Fujii M; Usami M; Shimamura M; Hirabayashi N; Kaneko T; Sasagawa N; Ishiura S
Biochem Biophys Res Commun; 2007 Dec; 364(4):883-8. PubMed ID: 17963693
[TBL] [Abstract][Full Text] [Related]
3. Computational models to predict endocrine-disrupting chemical binding with androgen or oestrogen receptors.
Chen Y; Cheng F; Sun L; Li W; Liu G; Tang Y
Ecotoxicol Environ Saf; 2014 Dec; 110():280-7. PubMed ID: 25282305
[TBL] [Abstract][Full Text] [Related]
4. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein.
Hong H; Branham WS; Ng HW; Moland CL; Dial SL; Fang H; Perkins R; Sheehan D; Tong W
Toxicol Sci; 2015 Feb; 143(2):333-48. PubMed ID: 25349334
[TBL] [Abstract][Full Text] [Related]
5. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
[TBL] [Abstract][Full Text] [Related]
6. Molecular interactions of vinclozolin metabolites with human estrogen receptors 1GWR-α and 1QKM and androgen receptor 2AM9-β: Implication for endocrine disruption.
Habib H; Haider MR; Sharma S; Ahmad S; Dabeer S; Yar MS; Raisuddin S
Toxicol Mech Methods; 2020 Jun; 30(5):370-377. PubMed ID: 32208804
[No Abstract] [Full Text] [Related]
7. Endocrine Disruption at the Androgen Receptor: Employing Molecular Dynamics and Docking for Improved Virtual Screening and Toxicity Prediction.
Wahl J; Smieško M
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914135
[TBL] [Abstract][Full Text] [Related]
8. Integration of in silico methods and computational systems biology to explore endocrine-disrupting chemical binding with nuclear hormone receptors.
Ruiz P; Sack A; Wampole M; Bobst S; Vracko M
Chemosphere; 2017 Jul; 178():99-109. PubMed ID: 28319747
[TBL] [Abstract][Full Text] [Related]
9. Predicting Potential Endocrine Disrupting Chemicals Binding to Estrogen Receptor α (ERα) Using a Pipeline Combining Structure-Based and Ligand-Based in Silico Methods.
Sellami A; Montes M; Lagarde N
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799614
[TBL] [Abstract][Full Text] [Related]
10. In silico identification and pharmacological evaluation of novel endocrine disrupting chemicals that act via the ligand-binding domain of the estrogen receptor α.
McRobb FM; Kufareva I; Abagyan R
Toxicol Sci; 2014 Sep; 141(1):188-97. PubMed ID: 24928891
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided identification of novel protein targets of bisphenol A.
Montes-Grajales D; Olivero-Verbel J
Toxicol Lett; 2013 Oct; 222(3):312-20. PubMed ID: 23973438
[TBL] [Abstract][Full Text] [Related]
12. Computational Study of Drugs Targeting Nuclear Receptors.
Kenda M; Sollner Dolenc M
Molecules; 2020 Apr; 25(7):. PubMed ID: 32244747
[TBL] [Abstract][Full Text] [Related]
13. Computational studies of interactions between endocrine disrupting chemicals and androgen receptor of different vertebrate species.
Wu B; Ford T; Gu JD; Zhang XX; Li AM; Cheng SP
Chemosphere; 2010 Jul; 80(5):535-41. PubMed ID: 20546840
[TBL] [Abstract][Full Text] [Related]
14. Theoretical study on endocrine disrupting effects of polychlorinated dibenzo-p-dioxins using molecular docking simulation.
Akinola LK; Uzairu A; Shallangwa GA; Abechi SE
J Appl Toxicol; 2021 Feb; 41(2):233-246. PubMed ID: 32656810
[TBL] [Abstract][Full Text] [Related]
15. Structure-based discovery of the endocrine disrupting effects of hydraulic fracturing chemicals as novel androgen receptor antagonists.
Tachachartvanich P; Azhagiya Singam ER; Durkin KA; Smith MT; La Merrill MA
Chemosphere; 2020 Oct; 257():127178. PubMed ID: 32505947
[TBL] [Abstract][Full Text] [Related]
16. Computational prediction models for assessing endocrine disrupting potential of chemicals.
Sakkiah S; Guo W; Pan B; Kusko R; Tong W; Hong H
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2018; 36(4):192-218. PubMed ID: 30633647
[TBL] [Abstract][Full Text] [Related]
17. Development, validation and integration of in silico models to identify androgen active chemicals.
Manganelli S; Roncaglioni A; Mansouri K; Judson RS; Benfenati E; Manganaro A; Ruiz P
Chemosphere; 2019 Apr; 220():204-215. PubMed ID: 30584954
[TBL] [Abstract][Full Text] [Related]
18. In silico methods in the discovery of endocrine disrupting chemicals.
Vuorinen A; Odermatt A; Schuster D
J Steroid Biochem Mol Biol; 2013 Sep; 137():18-26. PubMed ID: 23688835
[TBL] [Abstract][Full Text] [Related]
19. Identifying potential endocrine disruptors among industrial chemicals and their metabolites--development and evaluation of in silico tools.
Rybacka A; Rudén C; Tetko IV; Andersson PL
Chemosphere; 2015 Nov; 139():372-8. PubMed ID: 26210185
[TBL] [Abstract][Full Text] [Related]
20. Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.
Ng HW; Zhang W; Shu M; Luo H; Ge W; Perkins R; Tong W; Hong H
BMC Bioinformatics; 2014; 15 Suppl 11(Suppl 11):S4. PubMed ID: 25349983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
